Alebund Pharmaceuticals Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
169
- Stock Symbol
-
09637
- Share Price
-
$2.63
- (As of Friday Closing)
Alebund Pharmaceuticals General Information
Description
Alebund Pharmaceuticals (Jiangsu) Ltd is a biopharmaceutical company. Along with its subsidiaries, the company is principally engaged in the development, manufacturing, and commercialization of renal products. Its product portfolio in clinical and preclinical stages consists of one Core Product AP301 and six other product candidates, including one late-clinical-stage product candidate AP306, one early-clinical-stage product candidate (AP303), and four preclinical product candidates (AP308, AP304, AP305, and AP307). The company generated revenue from the sales of Mircera in China, a product used in the treatment of renal anemia.
Contact Information
Website
www.alebund.comCorporate Office
- Building 7, No. 7 Jinzhuang Road
- High-tech Zone, Hanjiang District
- Yangzhou, Jiangsu
- China
Corporate Office
- Building 7, No. 7 Jinzhuang Road
- High-tech Zone, Hanjiang District
- Yangzhou, Jiangsu
- China
Alebund Pharmaceuticals Timeline
Alebund Pharmaceuticals Stock Performance
As of 13-Nov-2026, Alebund Pharmaceuticals’s stock price is $2.63. Its current market cap is $914M with 348M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.63 | $2.70 | $1.83 - $5.97 | $914M | 348M | 816K | -$0.31 |
Alebund Pharmaceuticals Financials Summary
As of 30-Jun-2026, Alebund Pharmaceuticals has a trailing 12-month revenue of $17.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,992,925 | |||
| Revenue | 17,521 | 4,249 | 909 | |
| EBITDA | (87,244) | (83,151) | (40,941) | |
| Net Income | (100,582) | (104,298) | (45,436) | |
| Total Assets | 318,493 | 191,509 | 151,935 | |
| Total Debt | 84,872 | 78,526 | 65,636 |
Alebund Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alebund Pharmaceuticals Comparisons
Industry
Financing
Details
Alebund Pharmaceuticals Competitors (20)
One of Alebund Pharmaceuticals’s 20 competitors is Bicycle Therapeutics, a Formerly VC-backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bicycle Therapeutics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Dynavax Technologies | Formerly VC-backed | Emeryville, CA | ||||
| Zenith Epigenetics | Formerly VC-backed | Calgary, Canada | ||||
| Rhythm Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Oncorus | Formerly VC-backed | Andover, MA |
Alebund Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alebund Pharmaceuticals Patents
Alebund Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026166537-A1 | Methods for treating diabetic kidney disease | Pending | 10-Feb-2025 | ||
| WO-2026130352-A1 | Method for treating primary glomerulonephritis | Pending | 16-Dec-2024 |
Alebund Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alebund Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Alebund Pharmaceuticals FAQs
-
When was Alebund Pharmaceuticals founded?
Alebund Pharmaceuticals was founded in 2018.
-
Where is Alebund Pharmaceuticals headquartered?
Alebund Pharmaceuticals is headquartered in Yangzhou, China.
-
What is the size of Alebund Pharmaceuticals?
Alebund Pharmaceuticals has 169 total employees.
-
What industry is Alebund Pharmaceuticals in?
Alebund Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Alebund Pharmaceuticals a private or public company?
Alebund Pharmaceuticals is a Public company.
-
What is Alebund Pharmaceuticals’s stock symbol?
The ticker symbol for Alebund Pharmaceuticals is 09637.
-
What is the current stock price of Alebund Pharmaceuticals?
As of 13-Nov-2026 the stock price of Alebund Pharmaceuticals is $2.63.
-
What is the current market cap of Alebund Pharmaceuticals?
The current market capitalization of Alebund Pharmaceuticals is $914M.
-
What is Alebund Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Alebund Pharmaceuticals is $17.5M.
-
Who are Alebund Pharmaceuticals’s competitors?
Bicycle Therapeutics, Dynavax Technologies, Zenith Epigenetics, Rhythm Pharmaceuticals, and Oncorus are some of the 20 competitors of Alebund Pharmaceuticals.
-
What is Alebund Pharmaceuticals’s annual earnings per share (EPS)?
Alebund Pharmaceuticals’s EPS for 12 months was -$0.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
